PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Lab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.\', \'DIOSynVax, University of Cambridge, Cambridge, United Kingdom.\', \'Viral Pseudotype Unit, Medway School of Pharmacy, University of Kent, Chatham, United Kingdom.\', \'Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.\', \'Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.\', \'Department of Clinical Biochemistry and Immunology, Addenbrooke\'s Hospital, Cambridge, United Kingdom.\', \'Division of Virology, National Institute for Biological Standards and Control, Potters Bar, United Kingdom.\', \'UK Health Security Agency, Porton Down, United Kingdom.\', \'MRC Laboratory of Molecular Biology, Cambridge, United Kingdom.\', \'Complement Laboratory, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.\', \'Royal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.748291
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34867975
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
?:title
  • Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all